Therefore, we have here developed a first-of-its-kind QSP model focusing on MET-aberrant NSCLC that has incorporated detailed mechanistic features from the complex cellular signaling level all the way to the heterogeneous patient level. Here, MET is linked to non-small cell lung carcinoma.